Status
Conditions
Treatments
Study type
Funder types
Identifiers
About
Does a new "topping-off" device lead to a better clinical outcome compared to standard fusion? Does this device prevent the development of adjacent instability? Does radiological adjacent instability correlate with clinical outcome?
Full description
Primary efficacy endpoint:
The baseline and follow-up values after 6 weeks after the operation as well as 6 and 12 months after baseline of the SF-36 (Short-Form-36)-Measured Outcome regarding the Physical Component Summary (PCS).
Key secondary endpoint(s):
Assessment of safety:
Enrollment
Sex
Ages
Volunteers
Inclusion and exclusion criteria
Key inclusion criteria:
Key exclusion criteria:
Primary purpose
Allocation
Interventional model
Masking
30 participants in 2 patient groups
Loading...
Central trial contact
Jan Siewe, Dr.; Margarete Wicharz
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal